OTULFI 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Fresenius Kabi Deutschland Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 67dc0744b7178a0b
Drug Cima Aemps Name: OTULFI 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1241863003
Holder Company Name: Fresenius Kabi Deutschland Gmbh
Marketing Company Name: Fresenius Kabi España, S.A.U.
Holder Company Detail Path: /organization/fresenius-kabi-deutschland-gmbh
Authorization Date: 2024-09-30
Dosage Form: SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 130 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Fresenius Kabi Deutschland Gmbh
Company Detail Path: /organization/fresenius-kabi-deutschland-gmbh

USTEKINUMAB

130 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 30, 2024

Approval ID

67dc0744b7178a0b

Type

Standard